Journal List > J Rheum Dis > v.22(6) > 1064222

TOOLS
Choi: The Incidence of Uveitis in Ankylosing Spondylitis Patients Undergoing Tumor Necrosis Factor Inhibiting Therapy in Korea
Editorial

J Rheum Dis 2015;22(6):335-336.

Published online: 31 October 2015

DOI: https://doi.org/10.4078/jrd.2015.22.6.335

The Incidence of Uveitis in Ankylosing Spondylitis Patients Undergoing Tumor Necrosis Factor Inhibiting Therapy in Korea

Sung Jae Choi

Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea

Corresponding to: Sung Jae Choi, Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea. E-mail: csjmd888@korea.ac.kr

Received 13 November 2015       Accepted 16 November 2015

Copyright © 2015 The Korean College of Rheumatology

This is a Free Access article, which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.

REFERENCES

1. Max R, Lorenz HM, Mackensen F. Ocular involvement in spondyloarthropathies: HLA B27 associated uveitis. Z Rheumatol. 2010; 69:397–402.
2. Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015; 74:65–73.
3. Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis. 2008; 67:955–9.
4. Rudwaleit M, Rødevand E, Holck P, Vanhoof J, Kron M, Kary S, et al. Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis. 2009; 68:696–701.
5. Guignard S, Gossec L, Salliot C, Ruyssen-Witrand A, Luc M, Duclos M, et al. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis. 2006; 65:1631–4.
6. Wendling D, Paccou J, Berthelot JM, Flipo RM, Guillaume-Czitrom S, Prati C, et al. CRI. New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases. Semin Arthritis Rheum. 2011; 41:503–10.
7. Kim HS, Kim TJ, Bae SC, Yoo DH, Jun JB, Kim TH. TNF Inhibitors and uveitis in ankylosing spondylitis. J Korean Rheum Assoc. 2009; 16:48–53.
8. Koo BS, Hong S, Kim YJ, Lee CK, Yoo B, Kim YG. The incidence of uveitis in ankylosing spondylitis patients undergoing tumor necrosis factor inhibiting therapy in Korea. J Rheum Dis. 2015; 22:288–92.
TOOLS
DB Error: no database selected